Integumen’s Rinocloud wins tech award

Integumen acquired scientific data management specialist Rinocloud to develop its artificial intelligence platform earlier this year

Integumen - Integumen’s Rinocloud winds tech award in Ireland
Rinocloud is a scientific data management specialist

Integumen PLC’s (LON:SKIN) wholly-owned subsidiary Rinocloud was recognised as “one to watch” in TechLeaders19 IT award, which highlights the most innovative projects in the Irish tech sector.

Earlier this year, Integumen, the developer of the Labskin clinical research technology, acquired scientific data management specialist Rinocloud to develop its artificial intelligence platform.

READ: Integumen says two major cosmetics companies have signed up for LabskinAI services

“We are so honoured to have received this IT Leadership award in recognition of the Rinocloud team's creation of a disruptive drug discovery process for skin diseases such as psoriasis, eczema, acne and dandruff,” said Fin Murray, managing director of Rinocloud.

Quick facts: Integumen

Price: 1.84 GBX

Market: AIM
Market Cap: £19.73 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...



Integumen PLC 'the number one thought leader in skin microbiome and AI'

Integumen PLC's (LON:SKIN) Gerry Brandon recaps on 2019 and key highlights including the acquisition of RinoCloud and the deal done with Parity Group. Brandon adds that they're intending to double the size of its Labskin laboratory in York, currently at 3,162 square feet, which could provide...

on 20/12/19

2 min read